Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | SLC1A3 | P43003 | 3/20 | 0.33 |
| ▸ | SLC1A2 | P43004 | 3/20 | 0.33 |
| ▸ | SLC1A1 | P43005 | 3/20 | 0.33 |
| ▸ | SHBG | P04278 | 1/20 | 0.32 |
| ▸ | CTSL | P07711 | 1/20 | 0.32 |
| ▸ | CTSB | P07858 | 1/20 | 0.32 |
| ▸ | CTSK | P43235 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | CDK1 | P06493 | 1/20 | 0.30 |
| ▸ | CCNB1 | P14635 | 1/20 | 0.30 |
| ▸ | CCNA2 | P20248 | 1/20 | 0.30 |
| ▸ | CDK2 | P24941 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11883250 | 0.81 | HCRTR2 (0.30) | — | |
| SCHEMBL16191332 | 0.80 | SHBG (0.36) | SHBGCYP1A2 | |
| SCHEMBL27899696 | 0.80 | SLC1A3 (0.32) | LMNASLC1A3SLC1A2SLC1A1SHBG | |
| SCHEMBL16191184 | 0.80 | CYP1A2 (0.44) | SHBGCYP1A2 | |
| SCHEMBL20266033 | 0.79 | CTSK (0.35) | SLC1A3SLC1A2SLC1A1CTSLCTSB | |
| SCHEMBL23039739 | 0.79 | CTSL (0.41) | LMNASLC1A3SLC1A2SLC1A1CTSL | |
| SCHEMBL29101108 | 0.79 | CTSL (0.41) | LMNASLC1A3SLC1A2SLC1A1CTSL | |
| SCHEMBL869115 | 0.79 | CTSL (0.41) | LMNASLC1A3SLC1A2SLC1A1CTSL | |
| SCHEMBL16239892 | 0.79 | CTSL (0.41) | LMNASLC1A3SLC1A2SLC1A1CTSL | |
| SCHEMBL379081 | 0.79 | CTSL (0.41) | LMNASLC1A3SLC1A2SLC1A1CTSL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108203622-B | Organoleptic compounds | 国际香料和香精公司 | 2022-09-09 | — | — | CN | disclosed |
| EP-3339406-B1 | FRAGRANCE COMPOSITION | INT FLAVORS & FRAGRANCES INC (US) | 2020-02-12 | — | — | EP | disclosed |
| US-10273432-B2 | Organoleptic compounds | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 2019-04-30 | — | — | US | disclosed |
| US-10273432-B2 | Organoleptic compounds | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 2019-04-30 | — | — | US | disclosed |
| EP-3339406-A1 | FRAGRANCE COMPOSITION | International Flavors & Fragrances Inc. (US) | 2018-06-27 | — | — | EP | disclosed |
| CN-108203622-A | Novel sensory compounds | 国际香料和香精公司 | 2018-06-26 | — | — | CN | disclosed |
| US-20180171264-A1 | NOVEL ORGANOLEPTIC COMPOUNDS | INTERNATIONAL FLAVORS & FRAGRANCES INC. | 2018-06-21 | — | — | US | disclosed |
| US-20180171264-A1 | NOVEL ORGANOLEPTIC COMPOUNDS | INTERNATIONAL FLAVORS & FRAGRANCES INC. | 2018-06-21 | — | — | US | disclosed |
| US-20180171264-A1 | NOVEL ORGANOLEPTIC COMPOUNDS | INTERNATIONAL FLAVORS & FRAGRANCES INC. | 2018-06-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180171264-A1 | NOVEL ORGANOLEPTIC COMPOUNDS | TRPA1, TRPV1, TRPV5 | LMNA 3898/4885SLC1A3 3819/4885SLC1A2 3491/4885 |
| US-10273432-B2 | Organoleptic compounds | TRPA1, TRPV5, TRPV1 | LMNA 3692/4885SLC1A3 3368/4885SLC1A2 2991/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.